Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Patients

PhRMA’s New ‘Let’s Talk About Cost’ Campaign Convenes National Dialogue on Medicine Costs

Washington, DC, September 23, 2017Robert Zirkelbach, Executive Vice President of Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), in July posted on the association’s blog, The Catalyst:

Discussions about costs are important. We recognize that many are struggling to access the medicine they need and have important questions about their medicine costs.  And we want to help find the answers.

We recognize that many are struggling to access the medicine they need and have important questions about their medicine costs. And we want to help find the answers. Continue reading

HINJ’s ‘Value of Medical Innovation’ Portal Showcases How Life Sciences Is Saving Money — And Lives

Value Medical InnovationNew Brunswick, NJ, January 3, 2017 ― The HealthCare Institute of New Jersey (HINJ) continues to update its Value of Medical Innovation, a fact-driven, consumer-friendly digital library that delves into the myriad benefits of research-driven medical innovation, which saves money — and saves lives.

HINJ’s Value of Medical Innovation presents statistics from a number of resources, including the Advanced Medical Technology Association (AdvaMed), the Biotechnology Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA), U.S. government sources and various medical research organizations.

The Value of Medical Innovation page is the latest offering on HINJ.org, which was launched in February 2013 as part of HINJ’s strategic plan to build a dynamic communications capability that delivers relevant, robust and timely information to internal and external stakeholders. Continue reading

Politico: GOP Members of Congress to Start Obamacare Repeal in January — And Then Delay

Obamacare REPEALWashington, DC, November 17, 2016 — Jennifer Haberkorn reports in Politico that Republicans on Capitol Hill are growing confident that they can begin to repeal Obamacare once President-elect Donald Trump is sworn in, along with a pledge to replace it later.

Haberkorn reports that discussions among GOP lawmakers and with the Trump transition team are still taking shape.

But the goal is to move aggressively, getting points on the board against President Barack Obama’s health care law right away — as early as Inauguration Day itself, January 20. Continue reading

STAT News: Interview with PhRMA CEO: The One Drug Pricing Idea Clinton and PhRMA Can Agree On

Stephen J. Ubl

Stephen J. Ubl

Washington, DC, April 12 ― The pharmaceutical industry has opposed most of Secretary of State Hillary Clinton’s proposals to bring down drug costs, but there’s one idea its chief lobbyist supports: limiting the amount that consumers have to pay out of their own pockets, reports David Nather on STAT.

In an interview with STAT, Stephen J. Ubl, president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), the main trade group for drug companies, singled out the proposal when asked whether there were any positive ideas in the Democratic presidential front-runner’s drug prices plan.

“I would say one thing that she has proposed that we would favor is capping out-of-pocket costs,” Ubl said.  “I think we have to acknowledge that some patients do face challenges in accessing their medicines.” Continue reading

Partnership for Prescription Assistance Connects Millions of Patient; Celebrates 11th Anniversary, Launches Mobile App

Partnership for Prescription Assistance PPAWashington, DC, April 6 ― The Partnership for Prescription Assistance (PPA) yesterday celebrated 11 years of helping people who are struggling with affordable access to their medicines at the pharmacy.

In just over a decade, the program has helped connect nearly 10 million uninsured and underinsured patients to assistance programs that may provide the prescription medications they need for free or nearly free.

Pharmaceutical Research and Manufacturers of America (PhRMA) member companies invest heavily in research and development to discover innovative new medicines to help patients live longer, healthier lives.

But developing these medicines is not enough if patients are unable to access them.  Patient assistance programs sponsored by America’s biopharmaceutical research companies are one option to help patients maintain access to needed medicines.

PPA has multiple resources available for patients to access the information they may need.  Each month, more than 60,000 people visit the easy-to-use PPA website to find patient assistance programs and additional resources. Continue reading

Patients and Researchers Say ‘We’re Fighting Back’ in PhRMA’s New ‘From Hope to Cures’ Ads

PhRMA From Hope to CuresWashington, DC, March 13, 2016 ― Diagnosed with type 1 diabetes at a young age, five-year-old Rhys has not let his diagnosis be his destiny. He enjoys life to the fullest, from playing sports to having treats at a friend’s birthday party.

Fifteen years ago, Jamie was diagnosed with a rare blood cancer and thought she would not live to see her son grow up. Today, she’s happy, strong and planning a long-delayed trip to Paris with her husband.

Solving the world’s toughest health problems takes decades of research, but it also takes hope and courage from researchers. Jen, a biopharmaceutical scientist specializing in oncology, wakes up every day working to find new treatments and cures for patients.

Receiving a diagnosis is never easy, but thanks to biopharmaceutical innovation and researchers like Jen, patients like Rhys and Jamie have hope for brighter futures.

These are just a few of the stories featured in the Pharmaceutical Research and Manufacturers of America’s (PhRMA) 2016 “From Hope to Cures” advertising campaign. Continue reading

PhRMA Releases New Policy Solutions for Delivering Innovative Treatments to Patients

PhRMA jpgWashington, DC, March 10, 2016 ― Today, at the Pharmaceutical Research and Manufacturers of America’s (PhRMA) 2016 Annual Meeting, PhRMA president and CEO Stephen J. Ubl announced the association’s policy solutions for delivering innovative treatments to patients.

“I am a passionate believer in the power of biomedical innovation to save and improve lives,” Ubl said.  “We are on the cusp of a golden era in medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we can’t take this progress for granted.

“Now is the time for PhRMA to play a leadership role in advancing pragmatic, pro-consumer policies that enhance the private market and address costs holistically,” Ubl told attendees. Continue reading

Join ‘I’m Not Average,’ A Community for Patients, Supporters; Follow on Facebook, Twitter

PhRMA's I'm Not Average CampaignWashington, DC, February 17, 2016 ― Every patient has a powerful story.  This is the core belief that inspired the creation of “I’m Not Average,” an online campaign committed to sharing stories of hope in the face of illness thanks, in part, to innovative treatments and modern medicines, posts Ieva M. Augstums on The Catalyst, the Pharmaceutical Research and Manufacturers of America’s (PhRMA) content-rich blog.

Join the online “I’m Not Average” community on Facebook and Twitter, and show your support for those that embody strength during hardship.

Augstums writes, “Whether you are a patient yourself like 9-year-old Ellie, a caregiver like Diane, or a general supporter, we hope that this community serves as a vehicle for inspiration and encouragement for those that need it.” Continue reading

Patients and Researchers Say ‘We’re Fighting Back’ in PhRMA’s New ‘From Hope to Cures’ Ads

PhRMA From Hope to CuresWashington, DC, February 9, 2016 ― Diagnosed with type 1 diabetes at a young age, five-year-old Rhys has not let his diagnosis be his destiny. He enjoys life to the fullest, from playing sports to having treats at a friend’s birthday party.

Fifteen years ago, Jamie was diagnosed with a rare blood cancer and thought she would not live to see her son grow up. Today, she’s happy, strong and planning a long-delayed trip to Paris with her husband.

Solving the world’s toughest health problems takes decades of research, but it also takes hope and courage from researchers. Jen, a biopharmaceutical scientist specializing in oncology, wakes up every day working to find new treatments and cures for patients.

Receiving a diagnosis is never easy, but thanks to biopharmaceutical innovation and researchers like Jen, patients like Rhys and Jamie have hope for brighter futures.

These are just a few of the stories featured in the Pharmaceutical Research and Manufacturers of America’s (PhRMA) 2016 “From Hope to Cures” advertising campaign. Continue reading

Join ‘I’m Not Average,’ A Community for Patients, Supporters; Follow on Facebook, Twitter

PhRMA's I'm Not Average CampaignWashington, DC, December 16, 2015 ― Every patient has a story.  This is the core belief that inspired the creation of “I’m Not Average,” an online campaign committed to sharing stories of hope in the face of illness thanks, in part, to innovative treatments and modern medicines, posts Ieva M. Augstums on The Catalyst, the Pharmaceutical Research and Manufacturers of America’s (PhRMA) content-rich blog.

Join the online “I’m Not Average” community on Facebook and Twitter, and show your support for those that embody strength during hardship. Continue reading